FMRFamide-related peptides (FaRPs) have been found throughout the animal kingdom, and have been implicated in many functions, including cardiovascular control and neuromodulation. Recently, studies on mammalian FaRPs have shown evidence of anti-opioid activity, indicating a possible involvement in pain modulation. In C. elegans, FMRFamide-like immunoreactivity has been localized to about 10% of the neurons and at least six genes encoding these peptides have been identified.
flp-2 (PIRFamide-containing peptides),
flp-3 (FIRFamide-containing peptides),
flp-4 (TMRF-containing peptides), and
flp-5 (FIRFamide tetrapeptides?) were identified by the C. elegans genome sequencing project and are now being characterized in our lab. Reverse transcription/ PCR has confirmed that
flp-2 through
flp-4 are transcribed, and
flp-2 is alternatively spliced. The
flp-1 gene, genetically mapped to the right arm of chromosome IV, encodes multiple copies of FLRFamide-containing peptides. Animals carrying lacZ reporter constructs containing 1.5 kbp of the
flp-1 promoter region have shown that
flp-1 is expressed in RFamide immunoreactive interneurons in the head region of the animal. Further upstream regions have now been isolated and will be used to determine whether additional cells express the
flp-1 gene. To characterize the function of
flp-1, a
flp-1 deletion mutant, or "knockout", was isolated from population screens of
flp-1::Tc1 animals (kindly provided by Ron Plasterk). The deletion covered 1.4 kbp, and included almost 4 of the 6 exons as well as the start site of transcription. RFamide antibody staining of these animals showed an identical pattern to wild type animals, suggesting that
flp-1 peptides are colocalized with other FaRPs in all
flp-1-expressing cells. Multiple phenotypes have been correlated with the
flp-1 deletion. These phenotypes include: hyperactivity (as characterized by loopy movement, crawling off the agar,and excess foraging), nose-touch insensitivity, defects in osmolarity detection, and resistance to serotonin-induced egg-laying and sluggishness. Many of these phenotypes are also seen in mutants lacking the a subunit of the neuronal G protein. Rescue of these phenotypes with the wild type copy of the gene is currently underway. Further characterization of phenotypes in
flp-1 deletion animals as well as non-complementation screens for additional
flp-1 alleles are also ongoing.